SIMPONI ARIA® (golimumab) for healthcare professionals - Welcome. Learn about SIMPONI ARIA® (golimumab), a fully human anti-TNF infusion for the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.

  • https://www.simponiariahcp.com/medical-information-center-professional-product-sites Medical Information Center | SIMPONI ARIA® (golimumab) - Thank you for your interest in contacting Janssen Biotech, Inc. . Please note that we can only provide information about products marketed within the United States, and must refer international inquiries to our affiliates. For additional information, please contact Janssen Medical Information by using one of the following methods: Phone: Call 1-800-JANSSEN (1-800-526-7736) Email: Submit questions via our askjanssenmedinfo.com site
  • https://www.simponiariahcp.com/dosing Recommended dosing for SIMPONI ARIA® (golimumab) - SIMPONI ARIA® (golimumab) dosing and administration in the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/administration-instructions Administration instructions for SIMPONI ARIA® (golimumab) - Get step-by-step administration instructions for SIMPONI ARIA® (golimumab) for the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/dosing-calculator Dosing calculator for SIMPONI ARIA® (golimumab) - Calculate the dosage and number of vials of SIMPONI ARIA® (golimumab) needed for the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/efficacy/acr-response ACR response in patients treated with SIMPONI ARIA® (golimumab) - Read about ACR response rates with SIMPONI ARIA® (golimumab) in the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/efficacy/sharp-scores Sharp (vdH-S) scores in patients treated with SIMPONI ARIA® (golimumab) - Read about Sharp scores with SIMPONI ARIA® (golimumab) in the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/efficacy/haq-di-scores HAQ-DI scores in patients treated with SIMPONI ARIA® (golimumab) - Read about HAQ-DI scores with SIMPONI ARIA® (golimumab) in the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/efficacy/sf-36-scores SF-36 scores in patients treated with SIMPONI ARIA® (golimumab) - Read about SF-36 scores with SIMPONI ARIA® (golimumab) in the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/safety-profile/placebo-controlled-phase SIMPONI ARIA® (golimumab) safety profile - Learn about the safety profile of SIMPONI ARIA® (golimumab) in a clinical trial of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/safety-profile/controlled-and-uncontrolled-phase SIMPONI ARIA® (golimumab) safety profile in controlled and uncontrolled phase - Learn about the safety profile of SIMPONI ARIA® (golimumab) in the controlled and uncontrolled phase of a clinical trial of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/patientprofiles Patient Profiles | SIMPONI ARIA® (golimumab) | HCP - Read about people with moderately to severely active RA being treated with SIMPONI ARIA® (golimumab). Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/first-line-biologic-access First-line biologic access to SIMPONI ARIA® (golimumab) - Learn about first-line access to therapy with SIMPONI ARIA® (golimumab) for your adult patients with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/coverage-by-state State-specific coverage information for SIMPONI ARIA (golimumab) - Get state-specific coverage information for SIMPONI ARIA® (golimumab) for the treatment of adults with moderately to severely active rheumatoid arthritis. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/contract-purchasing-program Contract Purchase Program for SIMPONI ARIA® (golimumab) from Janssen Biotech, Inc. - Learn about CPP, a discount program for practices that provide in-office infusions with SIMPONI ARIA® (golimumab). Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/accessone Janssen CarePath support for patients treated with SIMPONI ARIA® (golimumab) - Learn about single-source support for access to therapy with SIMPONI ARIA® (golimumab). Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/additional-resources Resources for patients treated with SIMPONI ARIA® (golimumab) - Get an overview of resources for your patients being treated with SIMPONI ARIA® (golimumab) for moderately to severely active RA. Please see full Prescribing Information for SIMPONI ARIA®, including Boxed WARNINGS.
  • https://www.simponiariahcp.com/privacy-policy Privacy Policy | SIMPONI ARIA® (golimumab) - Janssen Biotech, Inc. is concerned about privacy issues and wants you to be familiar with how we collect, use, and disclose information. This Privacy Policy describes our practices in connection with information that we or our service providers collect through the Web site or Web property (including, for example, a mobile Web site or application) operated and controlled by us from which you are accessing this Privacy Policy (each, the “Site”). By providing personal information to us or by using the Site, you agree to the terms and conditions of this Privacy Policy.

    Country: 54.163.225.126, North America, US

    City: -77.4728 Virginia, United States

  • Diane Bear - Minoxidil 5% works for women!!!!

    My hair has been thinning for 20 years. My aunt lost almost all her hair and wore a wig in her old age, not from cancer or radiation. I went to a dermatologist a year ago who gave me a prescription for a steroid cream and recommended using minoxidil 5% twice a day except every weekend replacing it with the steroid cream as well as taking a high dose biotin 5x everyday.

  • Christie - It has good information that is helpful

    I am a vegan; he "makes" and recommends a pill that contains materials from animals that I would not eat. Sent Dr. Jason an E requesting he research another product suitable for vegans. It has good information that is helpful.

  • Ruben - I bought two of this and installed them in two ...

    I bought two of this and installed them in two of my cars. The first one is still working after 3 months, but the second one it started with noises from the engine and then completely stopped working. I contacted the seller and they're sending me a replacement.